Could a common steroid boost survival after severe stroke? new trial seeks answers
Disease control
Recruiting now
This study tests whether adding the steroid methylprednisolone to standard clot-removal treatment can improve survival and recovery in people who have had a severe stroke with a large area of brain damage and low immune cells. About 200 participants will receive either the drug o…
Phase: PHASE3 • Sponsor: YiLin • Aim: Disease control
Last updated May 20, 2026 11:56 UTC